| I-01 Thomas Dumortier Using extrapolation to support a pediatric investigational plan: an application in liver transplantation development Wednesday 10:20-11:40 |
| I-14 Aline Fuchs Simulations to simplify gentamicin dosing regimens for neonates and young infants when referral is not possible in developing countries Wednesday 10:20-11:40 |
| I-18 Eva Germovsek Pharmacokinetic-pharmacodynamic (PKPD) modelling of meropenem in plasma and cerebrospinal fluid (CSF) in infants with late-onset sepsis and/or bacterial meningitis Wednesday 10:20-11:40 |
| I-26 Verena Gotta Characterizing age-dependency of cytokine levels in healthy children Wednesday 10:20-11:40 |
| I-55 Carl Johansson Omeprazole dose recommendation in pediatric patients aged 1-11 months with erosive esophagitis Wednesday 10:20-11:40 |
| I-72 Jean Lavigne Modeling and simulation of smear count after administration of Eurartesim® (piperaquine (PQ) tetraphosphate/dihydroartemisinin (DHA)) in infected patients with Plasmodium falciparum malaria Wednesday 10:20-11:40 |
| II-17 Charlotte Barker Simultaneous modelling of antimicrobial pharmacokinetic data from birth to adolescence: using different penicillins to inform a common maturation function Wednesday 15:10-16:30 |
| II-21 Andrzej Bienczak Semi-physiological pharmacokinetic/pharmacogenetic model with circadian rhythm for the characterisation of nevirapine pharmacokinetics in African children. Wednesday 15:10-16:30 |
| II-29 Agnieszka Borsuk-De Moor Population pharmacokinetics of sufentanil after epidural and intravenous administration in children and infants Wednesday 15:10-16:30 |
| II-32 Jantine Brussee Predictive performance of a CRP and organ failure based pharmacokinetic model for midazolam in critically ill children across external datasets in neonates, children and adults Wednesday 15:10-16:30 |
| II-35 Elisa Calvier Allometric scaling of clearance in paediatrics: when does the magic of 0.75 fade? Wednesday 15:10-16:30 |
| II-47 Hyewon Chung Population pharmacokinetics of F-ara-A after fludarabine administration in pediatric hematopoietic stem cell transplantation patients Wednesday 15:10-16:30 |
| II-54 Sinziana Cristea Maturation of Glomerular Filtration throughout the paediatric age-range; a comparison of different functions Wednesday 15:10-16:30 |
| II-56 Salvatore D'Agate Optimisation of weight-banded dosing regimens of amoxicillin in neonates and young infants with sepsis Wednesday 15:10-16:30 |
| II-59 Pieter De Cock piperacillin-tazobactam pharmacokinetics in critically ill children: implications on adequate dosing regimens Wednesday 15:10-16:30 |
| II-64 Brenda de Winter Pharmacokinetics of Pentobarbital in Pediatric Status Epilepticus Patients Wednesday 15:10-16:30 |
| II-76 Hélder Duarte Amikacin in premature newborn: a new therapeutic proposal from a PopPK model Wednesday 15:10-16:30 |
| III-12 Adedeji Majekodunmi Mechanistic modelling of naive CD4+ T cell homeostasis in HIV-infected children on anti-retroviral therapy Thursday 10:05-11:30 |
| III-20 Paolo Mazzei Population exposure-response modeling of oral nepadutant administration in infants with colic Thursday 10:05-11:30 |
| III-28 Samer Mouksassi Primary microcephaly: do all roads lead to Rome? Thursday 10:05-11:30 |
| III-31 Silke Gastine Population Pharmacokinetics of Voriconazole in pediatric cancer patients - assessing new dosing strategies Thursday 10:05-11:30 |
| III-40 Sean Oosterholt Model-based extrapolation and dosing recommendation for raxibacumab in children from birth to <18 years of age Thursday 10:05-11:30 |
| III-45 Sophie Peigné Optimal design in the analysis of a clinical study in paediatric population Thursday 10:05-11:30 |
| III-60 Claire Pressiat Population pharmacokinetics of cotrimoxazole In West African HIV-infected children Thursday 10:05-11:30 |
| III-71 Christelle Rodrigues Population pharmacokinetics of oxcarbazepine and its 10-monohydroxy derivative in epileptic children Thursday 10:05-11:30 |
| IV-49 Swantje Völler Dose Recommendations for Recombinant Asparaginase in Children: A Population Pharmacokinetic Analysis Thursday 14:40-16:00 |
| IV-60 Pawel Wiczling A Bayesian approach for population pharmacokinetic modeling of dexmedetomidine during long-term infusion in critically ill pediatric patients. Thursday 14:40-16:00 |
| IV-62 Jayson Wilbur Zika microcephaly cutoffs revisited: A study of Non-parametric methods in fetal growth Thursday 14:40-16:00 |
| IV-63 Julia Winkler Population pharmacokinetics of lacosamide to support intravenous dose adaptation in children with epilepsy Thursday 14:40-16:00 |
